# Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-imatinib-longer-the-better-need-to-modify-risk-stratification-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anant Ramaswamy,Deepak Jain,Arvind Sahu,Joydeep Ghosh,Priya A. Prasad,Kedar Deodhar,Nitin Shetty,Shripad Banavali,Shailesh V. Shrikhande,Vikas Ostwal |
| Citations | 19 |
| DOI | 10.21037/jgo.2016.03.13 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://jgo.amegroups.com/article/viewFile/7314/pdf |
| OpenAlex ID | https://openalex.org/W2404477627 |
| PMID | 27563454 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Joydeep Ghosh](https://scholariq.org/researchers/joydeep-ghosh/)

## Paper primary topic

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Paper topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Gastrointestinal Bleeding Diagnosis and Treatment](https://scholariq.org/topics/gastrointestinal-bleeding-diagnosis-and-treatment/)
- [Gastrointestinal disorders and treatments](https://scholariq.org/topics/gastrointestinal-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.